Gaafar, Sherif <br/><br/>
Early onset of cabergoline therapy for prophylaxis from ovarian hyperstimulation syndrome (OHSS): A potentially safer and more effective protocol.  [electronic resource] 

 -  Reproductive biology  Jun 2019 
 - 145-148 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>2300-732X 
<br/><br/><label>Standard No.: </label>10.1016/j.repbio.2019.03.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cabergoline--administration & dosage<br/>Dopamine Agonists--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Fertility Agents, Female--adverse effects<br/>Gonadotropin-Releasing Hormone--administration & dosage<br/>Gonadotropins--administration & dosage<br/>Humans<br/>Ovarian Hyperstimulation Syndrome--drug therapy<br/>Polycystic Ovary Syndrome--drug therapy<br/>Risk Factors<br/>Sperm Injections, Intracytoplasmic<br/>Young Adult